Inventor · disambiguated record
Heinrich Haas
Also filed as: HAAS HEINRICH
20 granted patents·34 pending applications·74 citations·filing 2003–2025
93Inventor score
Top patents by PatentIndex Score
54 records- 0191US10576146B2Particles comprising a shell with RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2018·Granted Mar 3, 2020·13 cites·15 claims
- 0290US12059498B2Preparation and storage of liposomal RNA formulations suitable for therapyBioNTech SE·Filed 2021·Granted Aug 13, 2024·3 cites·26 claims
- 0389US11559587B2RNA formulation for immunotherapyBioNTech SE·Filed 2019·Granted Jan 24, 2023·3 cites·44 claims
- 0489US11395799B2Preparation and storage of liposomal RNA formulations suitable for therapyBioNTech SE·Filed 2018·Granted Jul 26, 2022·7 cites·31 claims
- 0589US10485884B2RNA formulation for immunotherapyBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2013·Granted Nov 26, 2019·16 cites·39 claims
- 0687US11045418B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2016·Granted Jun 29, 2021·3 cites·8 claims
- 0787US9950065B2Particles comprising a shell with RNABIONTECH AG·Filed 2013·Granted Apr 24, 2018·12 cites·20 claims
- 0886US11173120B2Stable formulations of lipids and liposomesBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2015·Granted Nov 16, 2021·4 cites·54 claims
- 0981US9238021B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2014·Granted Jan 19, 2016·2 cites·26 claims
- 1081US8075913B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMUNDUS CARSTEN·Filed 2010·Granted Dec 13, 2011·3 cites·16 claims
- 1177US11318195B2Formulation for administration of RNABIONTECH RNA PHARMACEUTICALS GMBH·Filed 2017·Granted May 3, 2022·1 cites·39 claims
- 1276US7794747B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMEDIGENE AG·Filed 2004·Granted Sep 14, 2010·6 cites·22 claims
- 1376US2025108008A1Preparation and storage of liposomal rna formulations suitable for therapyBioNTech SE·Filed 2024·Application pending·0 cites
- 1475US8663606B2Method of producing a cationic liposomal preparation comprising a lipophilic compoundMUNDUS CARSTEN·Filed 2011·Granted Mar 4, 2014·1 cites·22 claims
- 1573US11337922B2Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cellBIONTECH RNA PHARMACEUTICALS GMBH·Filed 2021·Granted May 24, 2022·0 cites·17 claims
- 1672US2023226217A1Rna formulation for immunotherapyTRON TRANSLATIONALE ONKOLOGIE AN DER UNIV DER JOHANNES GUTENBERG UNIV MAINZ AD·Filed 2022·Application pending·0 cites
- 1771US2025213599A1Formulation for administration of rnaBioNTech SE·Filed 2024·Application pending·0 cites
- 1870US2022249372A1Lipid Particle Formulations for Delivery of RNA and Water-Soluble Therapeutically Effective Compounds to a Target CellBioNTech SE·Filed 2022·Application pending·0 cites
- 1968US12220484B2Stable formulations of lipids and liposomesBioNTech SE·Filed 2021·Granted Feb 11, 2025·0 cites·20 claims
- 2065US11660338B2Particles comprising a shell with RNABioNTech SE·Filed 2020·Granted May 30, 2023·0 cites·27 claims
- 2163US12150947B2Formulation for administration of RNABioNTech SE·Filed 2019·Granted Nov 26, 2024·0 cites·16 claims
- 2263US2025367320A1RNA Particles Comprising PolysarcosineUNIV MAINZ JOHANNES GUTENBERG·Filed 2025·Application pending·0 cites
- 2363US2022313811A1Formulation for administration of rnaBioNTech SE·Filed 2022·Application pending·0 cites
- 2461US12419965B2RNA particles comprising polysarcosineUNIV MAINZ JOHANNES GUTENBERG·Filed 2019·Granted Sep 23, 2025·0 cites·11 claims
- 2560US2025281602A1Replicon Compositions and Methods of Using Same for the Treatment of DiseasesBioNTech SE·Filed 2023·Application pending·0 cites
- 2659US2010178243A1Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier systemMEDIGENE AG·Filed 2009·Application pending·0 cites
- 2758US2025263691A1Potency assay for therapeutic potential of coding nucleic acidBioNTech SE·Filed 2022·Application pending·0 cites
- 2857US2025375534A1Complexes for delivery of nucleic acidsBioNTech SE·Filed 2023·Application pending·0 cites
- 2957US2024408032A1Lipid-based rna formulations suitable for therapyBioNTech SE·Filed 2022·Application pending·0 cites
- 3056US12433911B2Preparation and storage of liposomal RNA formulations suitable for therapyBioNTech SE·Filed 2020·Granted Oct 7, 2025·0 cites·37 claims
- 3156US2025222097A1Lipid-based formulations for administration of rnaBioNTech SE·Filed 2022·Application pending·0 cites
- 3255US2025057960A1Oligosaccharide complexes and usesBioNTech SE·Filed 2022·Application pending·0 cites
- 3354US2024269321A1Preparation and storage of liposomal rna formulations suitable for therapyBioNTech SE·Filed 2021·Application pending·0 cites
- 3453US2024033344A1Pharmaceutical compositions comprising particles and mrna and methods for preparing and storing the sameBioNTech SE·Filed 2021·Application pending·0 cites
- 3552US2025057944A1Oligosaccharide complexes and usesBioNTech SE·Filed 2022·Application pending·0 cites
- 3652US2023390485A1Systems and methods for producing pharmaceutical compositions using peristaltic pumps and dampenersGENENTECH INC·Filed 2023·Application pending·0 cites
- 3751US2024417418A1Disulfide oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 3851US2025002522A1Oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 3951US2024425541A1Oligosaccharide compounds and complexesBioNTech SE·Filed 2022·Application pending·0 cites
- 4050US2022381748A1Method for determining at least one parameter of a sample composition comprising nucleic acid, such as rna, and optionally particlesBioNTech SE·Filed 2020·Application pending·0 cites
- 4150US2005181038A1Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier systemFiled 2004·Application pending·0 cites
- 4250US2023099898A1Composite rna particlesBioNTech SE·Filed 2021·Application pending·0 cites
- 4348US2012100067A1Solubilisation MethodFATTLER URSULA·Filed 2009·Application pending·0 cites
- 4447US2010297214A1Percolative drying for the preparation of particlesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4547US2010316696A1Liposome preparation by single-pass processMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4647US2023241223A1Rna particles comprising polysarcosineBioNTech SE·Filed 2021·Application pending·0 cites
- 4746US2007148221A1Method of producing lipid complexed camptothecin-carboxylateHAAS HEINRICH·Filed 2004·Application pending·0 cites
- 4846US2011002851A1Cationic Colloidal Carriers for Delivery of Active Agents to the Blood-Brain Barrier in the Course of Neuroinflammatory DiseasesMEDIGENE AG·Filed 2007·Application pending·0 cites
- 4943US2022362388A1Rna formulations suitable for therapyBioNTech SE·Filed 2020·Application pending·0 cites
- 5041US2007148196A1Method for producing colloidal nanoparticles with a compounderHAAS HEINRICH·Filed 2004·Application pending·0 cites
Showing the top 50 of 54 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Heinrich Haas files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →